# LIDOCAINE AND PRILOCAINE
> **ANDA213923** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2022-04-08
## Drug
- **FDA Application Number:** ANDA213923
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LIDOCAINE AND PRILOCAINE
- **Generic name:** LIDOCAINE AND PRILOCAINE
- **Active ingredients:** LIDOCAINE; PRILOCAINE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2022-04-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213923)
---
*AI Analytics · CC0 1.0*